Karyn Boundy

2.0k total citations
23 papers, 1.1k citations indexed

About

Karyn Boundy is a scholar working on Psychiatry and Mental health, Molecular Biology and Epidemiology. According to data from OpenAlex, Karyn Boundy has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Karyn Boundy's work include Dementia and Cognitive Impairment Research (7 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Karyn Boundy is often cited by papers focused on Dementia and Cognitive Impairment Research (7 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Karyn Boundy collaborates with scholars based in Australia, United Kingdom and United States. Karyn Boundy's co-authors include Henry Brodaty, David Ames, Mark Woodward, Robert Balshaw, Alastair Mander, Christopher C. Rowe, Peter Blumbergs, Eileen M. Moore, Kathryn A. Ellis and Donald R. Love and has published in prestigious journals such as Nature Genetics, Neurology and Diabetes Care.

In The Last Decade

Karyn Boundy

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karyn Boundy Australia 13 410 285 278 263 129 23 1.1k
Alfredo Postiglione Italy 24 177 0.4× 275 1.0× 245 0.9× 272 1.0× 183 1.4× 56 1.5k
Kenji Nakashima Japan 16 222 0.5× 316 1.1× 236 0.8× 376 1.4× 80 0.6× 65 1.6k
Yasuyo Mimori Japan 24 237 0.6× 287 1.0× 114 0.4× 422 1.6× 59 0.5× 67 1.6k
Jenna Collins United States 14 278 0.7× 307 1.1× 150 0.5× 302 1.1× 58 0.4× 33 1.7k
Aleksandra Pikula United States 20 233 0.6× 364 1.3× 314 1.1× 166 0.6× 164 1.3× 63 1.8k
K Kondo Japan 15 414 1.0× 590 2.1× 93 0.3× 521 2.0× 75 0.6× 31 1.7k
Mario Riverol Spain 21 175 0.4× 316 1.1× 74 0.3× 263 1.0× 57 0.4× 75 1.3k
Frank Hentschel Germany 19 209 0.5× 309 1.1× 145 0.5× 256 1.0× 121 0.9× 72 1.1k
Benjamin F.J. Verhaaren Netherlands 17 116 0.3× 205 0.7× 205 0.7× 392 1.5× 47 0.4× 31 1.5k
Sofiya Milman United States 23 573 1.4× 657 2.3× 74 0.3× 145 0.6× 306 2.4× 57 1.8k

Countries citing papers authored by Karyn Boundy

Since Specialization
Citations

This map shows the geographic impact of Karyn Boundy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karyn Boundy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karyn Boundy more than expected).

Fields of papers citing papers by Karyn Boundy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karyn Boundy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karyn Boundy. The network helps show where Karyn Boundy may publish in the future.

Co-authorship network of co-authors of Karyn Boundy

This figure shows the co-authorship network connecting the top 25 collaborators of Karyn Boundy. A scholar is included among the top collaborators of Karyn Boundy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karyn Boundy. Karyn Boundy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khoo, Anthony, et al.. (2019). Immune checkpoint inhibitor-related myositis associated with atezolizumab therapy. Neurology Clinical Practice. 9(3). e25–e26. 9 indexed citations
2.
Connors, Michael H., David Ames, Karyn Boundy, et al.. (2016). Mortality in Mild Cognitive Impairment: A Longitudinal Study in Memory Clinics. Journal of Alzheimer s Disease. 54(1). 149–155. 6 indexed citations
3.
Brodaty, Henry, Mark Woodward, Karyn Boundy, David Ames, & Robert Balshaw. (2013). Prevalence and Predictors of Burden in Caregivers of People with Dementia. American Journal of Geriatric Psychiatry. 22(8). 756–765. 129 indexed citations
4.
Moore, Eileen M., Alastair Mander, David Ames, et al.. (2013). Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care. 36(10). 2981–2987. 327 indexed citations
5.
Brodaty, Henry, Mark Woodward, Karyn Boundy, David Ames, & Robert Balshaw. (2011). Patients in Australian Memory Clinics: baseline characteristics and predictors of decline at six months. International Psychogeriatrics. 23(7). 1086–1096. 36 indexed citations
6.
Woodward, Mark, et al.. (2010). Does executive impairment define a frontal variant of Alzheimer's disease?. International Psychogeriatrics. 22(8). 1280–1290. 24 indexed citations
7.
Wilkinson, David, Gustavo C. Román, Stephen Salloway, et al.. (2009). The long‐term efficacy and tolerability of donepezil in patients with vascular dementia. International Journal of Geriatric Psychiatry. 25(3). 305–313. 18 indexed citations
8.
Lester, Sue, Tim Lu, Helen Keen, et al.. (2008). Mild autonomic dysfunction in primary Sjögren's syndrome: a controlled study. Arthritis Research & Therapy. 10(2). R31–R31. 30 indexed citations
9.
Boundy, Karyn, Henry Brodaty, & Michael Woodward. (2007). 607: Naturalistic treatment of Alzheimer’s disease with galantamine: 12-month follow-up from the NATURE study. Journal of Clinical Neuroscience. 14(10). 1019–1019. 1 indexed citations
10.
Brodaty, Henry, Mark Woodward, Karyn Boundy, Nicola Barnes, & Gabrielle Allen. (2006). A Naturalistic Study of Galantamine for Alzheimer???s Disease. CNS Drugs. 20(11). 935–943. 19 indexed citations
11.
Boundy, Karyn, Leighton Barnden, Andrew Katsifis, & Christopher C. Rowe. (2005). Reduced posterior cingulate binding of I-123 iodo-dexetimide to muscarinic receptors in mild Alzheimer’s disease. Journal of Clinical Neuroscience. 12(4). 421–425. 11 indexed citations
12.
Barnden, Leighton, et al.. (1998). Statistical parametric mapping in the detection of rCBF changes in mild Alzheimer's disease. Australian and New Zealand Journal of Medicine. 28(3). 381. 5 indexed citations
13.
Boundy, Karyn, Chris C. Rowe, Andrew Black, et al.. (1996). Localization of temporal lobe epileptic foci with iodine-123 iododexetimide cholinergic neuroreceptor single-photon emission computed tomography. Neurology. 47(4). 1015–1020. 9 indexed citations
14.
Mudford, Oliver C., et al.. (1995). The dexamethasone suppression test and the diagnosis of depression in adults with severe and profound developmental disabilities. Journal of Intellectual Disability Research. 39(4). 275–283. 2 indexed citations
15.
Laing, Nigel G., Steve D. Wilton, P. Anthony Akkari, et al.. (1995). A mutation in the α tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nature Genetics. 9(1). 75–79. 274 indexed citations
16.
Boundy, Karyn, Leighton Barnden, Christopher C. Rowe, et al.. (1995). Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors.. PubMed. 36(7). 1332–8. 15 indexed citations
17.
Soden, Muriel, et al.. (1994). Inclusion body myositis in association with rheumatoid arthritis.. PubMed. 21(2). 344–6. 14 indexed citations
18.
Nelson, John & Karyn Boundy. (1992). Magnetic Resonance Imaging in Carotid Dissection. Australasian Radiology. 36(1). 40–43. 5 indexed citations
19.
Frewin, D. B., G. G. Jamieson, W. J. Russell, et al.. (1989). EXTRA‐ADRENAL PHAEOCHROMOCYTOMA: REPORT OF THREE INTERESTING CASES. Australian and New Zealand Journal of Surgery. 59(9). 691–695. 6 indexed citations
20.
Boundy, Karyn & Leon P. Bignold. (1987). SYPHILITIC ANEURYSM OF THE RIGHT SUBCLAVIAN ARTERY PRESENTING WITH HEMOPTYSIS. Australian and New Zealand Journal of Medicine. 17(5). 533–535. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfredo Postiglione Breakdown of academic impact, for papers by Kenji Nakashima Breakdown of academic impact, for papers by Yasuyo Mimori Breakdown of academic impact, for papers by Jenna Collins Breakdown of academic impact, for papers by Aleksandra Pikula Breakdown of academic impact, for papers by K Kondo Breakdown of academic impact, for papers by Mario Riverol Breakdown of academic impact, for papers by Frank Hentschel Breakdown of academic impact, for papers by Benjamin F.J. Verhaaren Breakdown of academic impact, for papers by Sofiya Milman
Rankless by CCL
2026